Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
55 hedge funds and large institutions have $448M invested in Ventyx Biosciences in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more funds holding
Funds holding: 46 → 55 (+9)
2.67% more ownership
Funds ownership: 62.84% → 65.51% (+2.7%)
28% less capital invested
Capital invested by funds: $619M → $448M (-$171M)
41% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
+$9.22M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.49M |
| 3 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$4.48M |
| 4 |
Barclays
London,
United Kingdom
|
+$3.86M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.35M |
| 2 |
JP Morgan Chase
New York
|
-$744K |
| 3 |
Millennium Management
New York
|
-$726K |
| 4 |
HF
HRT Financial
New York
|
-$674K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$437K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $6K | -$32.3K | -2,419 | -86% |
|
|
HNWAG
52
High Net Worth Advisory Group
Naples,
Florida
| $4K | +$4.01K | +300 | New |
|
|
QCG
53
Quadrant Capital Group
Cincinnati,
Ohio
| $1K | +$1.34K | +100 | New |
|
|
HF
54
HRT Financial
New York
| – | -$674K | -33,963 | Closed |
|
|
TMAM
55
Tokio Marine Asset Management
Tokyo,
Japan
| – | -$246K | -12,400 | Closed |
|
|
PPA
56
Parametric Portfolio Associates
Seattle,
Washington
| – | -$217K | -10,934 | Closed |
|
57
Two Sigma Investments
New York
| – | -$214K | -10,760 | Closed |
|
|
TWA
58
TCI Wealth Advisors
Tucson,
Arizona
| – | -$2K | -84 | Closed |
|
|
CSS
59
Cubist Systematic Strategies
Stamford,
Connecticut
| – | +$347 | +26 | New |
|
60
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | +$481 | +36 | New |
|
VTYX Hedge Fund Activity: Q1 2022 in Review
55 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2022, worth a combined $448M — down 28% from $619M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VTYX positions and 5 closed out — a net gain of 9 holders — while 10 added to existing stakes and 17 trimmed.
The largest buyer was Logos Global Management, adding an estimated $9.22M. The largest seller was Wellington Management Group, cutting an estimated $4.35M.
- 55 institutional investors held Ventyx Biosciences (VTYX) as of Q1 2022, up from 46 in Q4 2021.
- Funds reported $448M of Ventyx Biosciences stock for Q1 2022, down 28% quarter-over-quarter.
- 14 funds opened new Ventyx Biosciences positions in Q1 2022 and 5 closed out, a net change of +9 holders.
- The largest Ventyx Biosciences buyer in Q1 2022 was Logos Global Management, an estimated $9.22M added.
- The largest Ventyx Biosciences seller in Q1 2022 was Wellington Management Group, an estimated $4.35M sold.
Based on aggregated 13F filings for Q1 2022.